WHAT THIS PAPER ADDS Excellent long-term secondary patencies are described after percutaneous mesenteric artery stenting in a well defined cohort of patients with acute and chronic mesenteric ischaemia. This study underscores the evolving role for endovascular treatment in mesenteric ischaemia, from "bridge to surgery" to first choice treatment and "bridge to repeat endovascular treatment" in most patients with acute and chronic mesenteric ischaemia.Introduction: Over the past decade, primary percutaneous mesenteric artery stenting (PMAS) has become an alternative to open revascularisation for treatment of mesenteric ischaemia. Institutes have presented favourable short-term outcomes after PMAS, but there is a lack of data on long-term stent patency. Methods: One hundred and forty-one patients treated by PMAS for acute and chronic mesenteric ischaemia over an 8 year period were studied. Anatomical success was assessed by duplex ultrasound and/or CT angiography. A stenosis 70% was considered to be a failure. Results: Eighty-six coeliac arteries (CA) and 99 superior mesenteric arteries (SMA) were treated with PMAS in 141 patients. Nine CAs (10%) and 30 SMAs (30%) were occluded at the time of treatment. Median follow-up was 32 months (IQR 20e46). The overall primary patency rate at 12 and 60 months was 77.0% and 45.0%. The overall primary assisted patency rate was 90.3% and 69.8%. Overall secondary patency was 98.3% and 93.6%. Conclusion: This study shows excellent long-term secondary patencies after PMAS, comparable with published data on long-term patencies after open surgical revascularisation. Ó